Sponsored by:

Molecular Imaging

PET/CT shows value in patients with soft-tissue sarcomas
By Will Morton
PET/CT scans can help identify which patients are most likely to benefit from treatment.
October 13, 2025
Pet Ct Scanner
SNMMI updates radioisotope production status in U.S.
By AuntMinnie.com staff writers
Projects noted in an October 10 update include IAEA's disused radium transfer program and others.
October 10, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
PSMA-PET/CT may replace NaF-PET/CT in advanced prostate cancer
By Will Morton
Replacing F-18 sodium fluoride (NaF) PET/CT with F-18 PSMA PET/CT can improve treatment for men with newly diagnosed prostate cancer.
October 10, 2025
2025 10 09 Jnumed Psma Pet Vs Na F Pet Thumbnail
GLP-1 drugs may confound PET/CT imaging findings
By AuntMinnie.com staff writers
The drugs are now widely prescribed for people with type 2 diabetes -- with a 700% use increase in the U.S. between 2019 and 2023.
October 7, 2025
Semaglutide Injection Pen
PSMA PET-guided radiotherapy shows promise
By Will Morton
A trial demonstrated that radiotherapy informed by PSMA-PET led to improved outcomes in prostate cancer patients.
October 3, 2025
Prostate Imaging
PET reveals mechanism underlying brain fog in long COVID
By Will Morton
Brain regions where C-11 K-2 radiotracer was increased were negatively correlated with long-COVID patients’ performance on cognitive tests.
October 2, 2025
2025 10 02 Long Covid Apar Thumbnail
SpectronRx’s Ac-225 boosted for use in Canada
By AuntMinnie.com staff writers
Ac-225 is a highly sought-after alpha-emitting isotope that shows promise for targeted cancer therapy.
October 1, 2025
Isotopes1
NAPT survey results show promise for proton therapy adoption
By Amerigo Allegretto
Proton therapy continues to experience increased clinical use, but barriers to care continue to limit its potential.
September 29, 2025
Survey Form 400
CPDC launches Cadena Research for radiopharmaceutical development
By AuntMinnie.com staff writers
The CPDC has launched Cadena Research, a new preclinical CRO offering support for early-stage radiopharmaceuticals.
September 29, 2025
Radiotherapy2 400
Case report: Pluvicto as a first-line treatment in late-stage prostate cancer
Since 1996, the patient continually declined androgen deprivation therapy, chemotherapy, and local therapy to the prostate gland.
September 26, 2025
Burden of PSMA-expressing prostate cancer before and after treatment with two cycles of Lu-177 PSMA-617. (A and B) Reduction in overall disease burden is evident after treatment. Avidity of patient’s primary prostate tumor and his osseous metastasis shown before (C) and after (D) treatment.
Lantheus and GEHC to launch PET agent for prostate imaging in Japan
By AuntMinnie.com staff writers
GEHC will draw on its manufacturing network and R&D expertise following its acquisition in March 2025 of Nihon Medi-Physics.
September 24, 2025
Prostate Imaging
NorthStar partners with Univ. of Wisconsin on radiopharma research
By AuntMinnie.com staff writers
The multiyear project furthers the goal of turning southern Wisconsin into a nuclear medicine hub.
September 23, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
Page 1 of 615
Next Page